Leveraging an Industrial–Academic Partnership To Optimize Small Molecule Process Development within the Pharmaceutical Industry

2015 ◽  
Vol 19 (2) ◽  
pp. 344-346 ◽  
Author(s):  
Rebecca E. Deasy ◽  
Catherine N. Slattery ◽  
Marie Kissane ◽  
Orla A. McNamara ◽  
Denis Lynch ◽  
...  
Keyword(s):  
Pharmaceutical Industry ◽  
Small Molecule ◽  
Process Development

Integrated continuous manufacturing in pharmaceutical industry: current evolutionary steps toward revolutionary future

2019 ◽  
Vol 8 (4) ◽  
pp. 139-161 ◽  
Author(s):  
Nada A Helal ◽  
Ola Elnoweam ◽  
Heba Abdullah Eassa ◽  
Ahmed M Amer ◽  
Mohamed Ashraf Eltokhy ◽  
...  
Keyword(s):  
Pharmaceutical Industry ◽  
Process Development ◽  
State Of The Art ◽  
Scale Up ◽  
Pharmaceutical Products ◽  
Continuous Manufacturing ◽  
Monitoring And Control ◽  
Pharmaceutical Manufacturers ◽  
On Line ◽  
And Control

Continuous manufacturing (CM) has the potential to provide pharmaceutical products with better quality, improved yield and with reduced cost and time. Moreover, ease of scale-up, small manufacturing footprint and on-line/in-line monitoring and control of the process are other merits for CM. Regulating authorities are supporting the adoption of CM by pharmaceutical manufacturers through issuing proper guidelines. However, implementation of this technology in pharmaceutical industry is encountered by a number of challenges regarding the process development and quality assurance. This article provides a background on the implementation of CM in pharmaceutical industry, literature survey of the most recent state-of-the-art technologies and critically discussing the encountered challenges and its future prospective in pharmaceutical industry.

scholarly journals Small Molecule Microcrystal Electron Diffraction (MicroED) for the Pharmaceutical Industry – Results from Examining Over Fifty Samples

2021 ◽  
Vol 27 (S1) ◽  
pp. 2594-2598
Author(s):  
Jessica Bruhn ◽  
Giovanna Scapin ◽  
Anchi Cheng ◽  
Thejusvi Ganesh ◽  
Sargis Dallakyan ◽  
...  
Keyword(s):  
Pharmaceutical Industry ◽  
Electron Diffraction ◽  
Small Molecule

ChemInform Abstract: Process Development of 4-[N-Methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline Dihydrochloride (VI): A Key Intermediate for TAK-779 (VII), a Small-Molecule Nonpeptide CCR5 Antagonist.

ChemInform ◽  
2010 ◽  
Vol 33 (23) ◽  
pp. no-no
Author(s):  
Hideo Hashimoto ◽  
Tomomi Ikemoto ◽  
Tatsuya Itoh ◽  
Hideaki Maruyama ◽  
Tadashi Hanaoka ◽  
...  
Keyword(s):  
Small Molecule ◽  
Process Development ◽  
Ccr5 Antagonist

scholarly journals Small-molecule microcrystal electron diffraction (MicroED) for the pharmaceutical industry

2020 ◽  
Vol 76 (a1) ◽  
pp. a110-a110
Author(s):  
Jessica Bruhn ◽  
Anchi Cheng ◽  
Travis Nieusma ◽  
Sargis Dallakyan ◽  
Jeff Speir ◽  
...  
Keyword(s):  
Pharmaceutical Industry ◽  
Electron Diffraction ◽  
Small Molecule

scholarly journals Key strategic issues pharmaceutical industry of SCM: A systematic literature review

2020 ◽  
Vol 9 (2) ◽  
pp. 808-817
Author(s):  
Erick Fernando ◽  
Meyliana Meyliana ◽  
Harco Leslie Hendric Spits Warnars ◽  
Edi Abdurachman
Keyword(s):  
Supply Chain ◽  
Supply Chain Management ◽  
Pharmaceutical Industry ◽  
Inventory Management ◽  
Capacity Planning ◽  
Lean Manufacturing ◽  
Process Development ◽  
Chain Management ◽  
Strategic Issues ◽  
Development Capacity

In this global era, making the competition in the pharmaceutical industry is very treacly. Implementation Supply chain management is the process of planning and managing all sourcing, procurement, distribution activities to increase value to customers and interested companies. Pharmaceutical companies are one that has a very complex supply chain. In this article will discuss the main issues that can improve industry strategic. This research is done by the systematic approach of literature to find things related to research. This study used 64 articles from search results. The results of this search are key issues in the pharmaceutical industry such as product and process development, capacity planning, factory and network design, e-business and IT applications, inventory management, outsourcing and reverse logistics, lean manufacturing, performance measures, people, and information technology. All of these findings are issues that improve the performance of supply chain management in the pharmaceutical industry.

Sign in / Sign up

Export Citation Format

Share Document